The U.S. Supreme Court will review an overtime pay case from a nationwide class of GlaxoSmithKline pharmaceutical sales representatives.
The top pre-market NASDAQ Stock Market gainers are: Pozen, Transcept Pharmaceuticals, Yahoo, Infosys, and Research In Motion. The top pre-market NASDAQ Stock Market losers are: ASM International, ARM Holdings, Randgold Resources, ASML Holding, and Rediff.com India.
The top after-market NASDAQ Stock Market gainers are: Pozen, Andatee China Marine Fuel Services, Power-One, Cirrus Logic, and Spectrum Pharmaceuticals. The top after-market NASDAQ Stock Market losers are: BGC Partners, Jack Henry & Associates, Perion Network, Alaska Communications Systems Group, and Dendreon.
More people than ever are living with the AIDS virus but this is largely due to better access to drugs that keep HIV patients alive and well for many years, the United Nations AIDS program (UNAIDS) said on Monday.
The GAVI international immunizations group has agreed to fund the roll-out of vaccines against cervical cancer in developing countries, offering protection against a disease that kills one woman every two minutes.
Superbugs capable of evading even the most powerful antibiotics are increasing their grip in Europe with rates of drug resistance in one type of bacteria reaching 50 percent in the worst-hit countries, health officials said Thursday.
Malaria-resistant people have mutated red blood cells that resist the parasite's ability to steal that necessary cellular scaffold, according to research published Thursday in the online edition of Science, uncovering a puzzle years in the making.
Britain's GlaxoSmithKline has agreed to pay billions of dollars to settle multiple U.S. pharmaceutical investigations.
U.S. vaccine advisers on Tuesday voted to recommend that boys be routinely vaccinated with Merck & Co's Gardasil vaccine to protect them from human papillomavirus or HPV infections, which cause genital warts and oral, penile and anal cancers in males and cervical cancers in women.
A new vaccine cuts children's chances of contracting malaria in half, according to a major clinical trial sub-Saharan Africa. It is the first successful malaria vaccine and could be an indispensable tool in the fight to eradicate the disease.
An experimental vaccine from GlaxoSmithKline halved the risk of African children getting malaria in a major clinical trial, making it likely to become the world's first shot against the deadly disease.
U.S. health officials are looking to capitalize on significant gains in flu vaccination rates with a new campaign emphasizing the need for all Americans over six months of age to get a flu shot.
The issue of the longevity gene has now created a feud between two trans-Atlantic camps of researchers. While the British scientists claim the days of longevity gene are over, the US scientists still have faith in the success of the gene.
A gene scientists say delivers the fountain of youth may just a bucket of water, according to research published today.
Scientists have found a way to prevent HIV from damaging the immune system and say their discovery may offer a new approach to developing a vaccine against AIDS.
Scientists have found a way to prevent HIV from damaging the immune system and say their discovery may offer a new approach to developing a vaccine against AIDS.
